Literature DB >> 14563119

MicroRNAs and cancer.

Michael T McManus1.   

Abstract

The general basis of cancer is the loss of cell identity and inappropriate proliferation of cells. Classically, a universal paradigm in oncogenesis is the accumulation of mutations in the open reading frames of protein-encoding oncogenes and tumor suppressors. The identification of new classes of noncoding RNAs (ncRNA) important for development and cell homeostasis will likely change this current paradigm. Recent data suggests that a special class of ncRNAs called microRNAs might be involved in human disease. This review proposes a role for microRNAs in oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563119     DOI: 10.1016/s1044-579x(03)00038-5

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  132 in total

1.  Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.

Authors:  Suman Bhatia; Deepak Kaul; Neelam Varma
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

2.  Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells.

Authors:  Xiao-Yan Wang; Ming-Hua Wu; Fen Liu; Yu Li; Nan Li; Gui-Yuan Li; Shou-Rong Shen
Journal:  Mol Cell Biochem       Date:  2010-09-22       Impact factor: 3.396

Review 3.  Molecular diagnostics in transplantation.

Authors:  Maarten Naesens; Minnie M Sarwal
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

4.  Higher miRNA tolerance in immortal Li-Fraumeni fibroblasts with abrogated interferon signaling pathway.

Authors:  Qunfang Li; Michael A Tainsky
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

5.  Network analysis of microRNAs and genes in human osteosarcoma.

Authors:  Tianyan Wang; Zhiwen Xu; Kunhao Wang; Ning Wang
Journal:  Exp Ther Med       Date:  2015-08-17       Impact factor: 2.447

6.  MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5.

Authors:  Hui Xu; Dan Fei; Shan Zong; Zhimin Fan
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

7.  MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.

Authors:  Jinhai Li; Yuanyuan Guo; Xiaodi Liang; Ming Sun; Guoliang Wang; Wei De; Wenxi Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-22       Impact factor: 4.553

8.  microRNAs exhibit high frequency genomic alterations in human cancer.

Authors:  Lin Zhang; Jia Huang; Nuo Yang; Joel Greshock; Molly S Megraw; Antonis Giannakakis; Shun Liang; Tara L Naylor; Andrea Barchetti; Michelle R Ward; George Yao; Angelica Medina; Ann O'brien-Jenkins; Dionyssios Katsaros; Artemis Hatzigeorgiou; Phyllis A Gimotty; Barbara L Weber; George Coukos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 9.  Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.

Authors:  George A Calin; Carlo M Croce
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 10.  MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.

Authors:  Satyanarayana Rachagani; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2009-12-09       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.